Abiopharma

🔍 Chan Christopher H.M. (Executive)

Company: FIRST BUSEY CORP /NV/ (BUSE)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 329 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 33,964.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents dividend equivalent rights accrued on Restricted Stock Units in connection with the payment of a cash dividend on First Busey Corporation Common Stock. Each dividend equivalent right is the economic equivalent of one share of First Busey Corporation Common Stock.